Fig. 2From: Intraarterial transplantation of human umbilical cord blood mononuclear cells in hyperacute stroke improves vascular functionLine graphs of the (a) foot-fault test and (b) cylinder test of a vehicle- and stem cell-treated animal before middle cerebral arterial occlusion (MCAO) (Pre), and at 2, 7, 14, and 28 days post-MCAO (n = 6 per group; mean ± SEM). *P < 0.05, **P < 0.01, versus the PBS vehicle. hUCB human umbilical cord blood, MNC mononuclear cellBack to article page